Form 4 for INSM INSMED Inc
Accepted 2025-12-09 00:00:00 ET · period of report 2025-12-05 · accession 0001182633-25-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-09 | 2025-12-05 | INSM | SHAROKY MELVIN MD | Dir | S - Sale | $205.01 | -20.0K | 243.9K | -8% | -$4.10M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-05 | S | D | 20,000 | $205.01 | 243,948 | D | — | — | (F1) This is the weighted average sales price representing 20,000 shares sold at prices ranging from $205.00 to $205.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. (F2) Reflects shares acquired in pro rata distributions of 23 and 1,250 shares from Baby Gator LLC and Padonia, LLC, respectively, each of which transactions were exempt from reporting pursuant to Rule 16a-9 and Rule 16a-13. |